Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry - Wikidata - awgldk - TriplyDB

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

http://www.wikidata.org/entity/Q27490785

about

Entry inhibitors: New advances in HCV treatment Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction Emerging antivirals for the treatment of hepatitis B.Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle Emerging drugs for varicella-zoster virus infections.Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Hepatitis C virus experimental model systems and antiviral drug research.Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.How hepatitis C virus invades hepatocytes: the mystery of viral entry Amphipathic properties of HIV-1 gp41 fusion inhibitors.Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection.New insights in recurrent HCV infection after liver transplantation Hepatitis C virus infection and related liver disease: the quest for the best animal model Liver cell-targeted delivery of therapeutic molecules.Targeting HCV entry for development of therapeutics.Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.Evaluation of antiviral drug synergy in an infectious HCV system.Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.Gumming up the works: DNA polymers as HCV entry inhibitors.Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.Cellular microRNA networks regulate host dependency of hepatitis C virus infection.Activity of nucleic acid polymers in rodent models of HBV infection.Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.Hepatitis C virus: Morphogenesis, infection and therapy.Blocking HCV entry as potential antiviral therapy

P2860

Q26770817-7A444164-1990-4C04-AE51-581A8039F210 Q26779128-153B3BC9-95D0-402F-A8CB-81A206736574 Q33638356-A8688793-AB7D-4A1F-923D-FD599BE0FF84 Q33801328-0453924D-BB36-4A21-AF61-1A857F75610C Q33821878-6D63390E-7FCE-455D-8076-97DBC5AF1310 Q33893794-6914D514-2840-4205-8E14-4502F502CC6B Q34027426-00058576-DC36-4FDF-9E70-E113CB9E4A60 Q34084050-A0F6F13C-8D97-4529-9D4E-7F182FFCEF75 Q34093754-EDB63E62-A7E6-4AC4-9B35-DAF5B4D10362 Q34235286-EC7B40A8-F91B-4A2D-BE3D-B40DC316B6ED Q34245963-EF3C259E-15C7-4BFE-A0FC-C7AF285B9865 Q35093800-FBB53875-427B-42B1-A177-EB32EDF66243 Q35135565-CF2C4C14-B70B-468C-BA99-7BE4A52B585F Q35839139-C3137CD8-8A62-45DD-BEF6-73A4A457BF2F Q37477905-4C6910E5-8181-49DC-84C1-E6BF2242E37E Q37682499-3DA113A9-F756-40BB-AD27-DFAF2089C261 Q37951610-E7DCB970-7BCD-4887-A3D0-A27C2E7161AE Q38103293-99E64092-651F-4224-AB5E-F5A4B2611148 Q38109628-876514AE-ED91-4315-9B0D-E5824904A95F Q38125192-DF081060-E8A7-4A00-8208-BE75A5035818 Q38229624-8F3F7FB5-1770-4083-9E34-2761850DA99F Q38615654-AC3120FE-D666-4B46-AF5C-A2469BB204A9 Q39368000-207DF895-3D87-4C1C-9BED-08E590DF855A Q39871877-585D85B3-B560-432B-8CA7-FD218AE0BF1A Q40302798-B80B35AF-694E-4191-A9E3-856C9C26B196 Q42277109-D0EAB6ED-75D6-4C40-8F36-9C171A161F4C Q42426768-1A8A852C-BD1B-4DAA-8758-3B2509E67AEF Q42772176-5F5E510F-3FD6-44C4-B661-89725F3C383B Q45323707-17C28896-0AC5-45DE-8D6D-BC07411B0C0A Q45324234-466678C5-AC70-4B86-889A-825BEE19D7E3 Q46263692-7A4C9981-E97B-40CA-A1F9-B3D2D31B51FE Q52655967-2E51E714-34D0-419B-8799-90BD73FE8DDD Q52661702-98225B7B-EC1B-4753-9916-BCF5D22CF239 Q57241788-A369E6F7-B33B-4538-88BF-6B93835FE1DB

P2860

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

http://www.wikidata.org/entity/Q27490785

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@ast

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@en

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@nl

type

label

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@ast

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@en

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@nl

prefLabel

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@ast

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@en

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

@nl

P1433

Q27490785-06A94BC5-E462-4A57-ACCE-8D97C1455023

P1476

Q27490785-01B2FCC7-1095-435A-B107-E73C14370DE3

P2093

Q27490785-14E82A45-22FF-455C-8A73-C5D9ABDE6CC7

Q27490785-4DE457D5-4F6A-4C99-AE46-2BD47F466970

Q27490785-70A98CD3-A14F-477D-AC96-212243AC9299

Q27490785-8EF12FC3-1980-4304-88C7-D01CCB8881AD

Q27490785-904503BD-E9BD-46F3-80A5-F01C5BF2A1ED

Q27490785-95CFD709-9E8A-4DA5-BDE1-275256C260C0

Q27490785-98A11269-3B2E-4B4A-A79A-6B4118205134

Q27490785-BA96CD30-F9A4-4497-8537-8AFA88DED2FB

Q27490785-D7A7A3EC-FEB2-4625-BE8D-316622EBA5A7

Q27490785-F82D7DC4-4AEF-4C77-8343-0045D2B26BA2

P2860

Q27490785-07DF7391-5FF4-4336-AD24-6608611E7E18

Q27490785-08A484CF-C5A1-4A0A-8B8D-81F45028C97C

Q27490785-0B5B7F0C-2825-4A56-B3CE-5503470A86B2

Q27490785-121131B3-0B69-4D2C-8019-68D60FCDC014

Q27490785-131C4D15-5D0B-427C-B2E2-9FE3708424B7

Q27490785-14A41B70-EC01-48F8-AFF7-C289ABC30134

Q27490785-1DB59199-50CA-4131-8EC9-7DE205C5179A

Q27490785-25947585-78C0-4E55-A987-D0DF0C793549

Q27490785-268B0A64-BF54-42B3-81EE-5740DB0D9688

Q27490785-2BE6DFF1-BEBE-4F67-92F5-4439193F6E76

P304

Q27490785-21911122-EE13-41A5-9BD5-AFE7674BBC48

P31

Q27490785-CE3CA6AC-6060-4CC3-AF61-A20787A1CFE4

P356

Q27490785-59C2E13C-90E6-4493-A076-F5CCED4B55E6

P407

Q27490785-EBCC9788-32B9-44B1-BFD3-6706D03E40CC

P433

Q27490785-7F5E96CB-B698-4C0B-A9AE-B34D537AF31D

P478

Q27490785-E3EFC6EB-7422-4B76-9E0D-61C7797F21DA

P50

Q27490785-29A5ABA0-E5ED-4B95-A381-513F1B4F1ED3

Q27490785-97AFECEA-43D8-42BF-AEC3-D42A2171CAEE

P577

Q27490785-7DD8F7C1-DF83-4C37-A1C8-0DAF73C15DCA

P5875

Q27490785-4E70CAC6-91B7-4797-A982-942E2932BD5C

P698

Q27490785-776B119C-65CB-4CBE-BA0F-C62FB6A3A57E

P932

Q27490785-4E530F49-541A-4C13-B6CA-54554C4C3C62

P356

J.GASTRO.2009.04.048

P1433

Gastroenterology

P1476

Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry

@en

P2093

Andrew Vaillant

http://www.w3.org/2001/XMLSchema#string

Jean-Marc Juteau

http://www.w3.org/2001/XMLSchema#string

Kazuaki Chayama

http://www.w3.org/2001/XMLSchema#string

Michio Imamura

http://www.w3.org/2001/XMLSchema#string

Nobuhiko Hiraga

http://www.w3.org/2001/XMLSchema#string

T Jake Liang

http://www.w3.org/2001/XMLSchema#string

Takanobu Kato

http://www.w3.org/2001/XMLSchema#string

Takuya Matsumura

http://www.w3.org/2001/XMLSchema#string

Yong-Yuan Zhang

http://www.w3.org/2001/XMLSchema#string

Zongyi Hu

http://www.w3.org/2001/XMLSchema#string

P2860

How Viruses Enter Animal Cells

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

The SH3 binding motif of HCV [corrected] NS5A protein interacts with Bin1 and is important for apoptosis and infectivity

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.

Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.

Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.

P304

673-681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2009.04.048

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

François-Loïc Cosset

P577

2009-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24360048

http://www.w3.org/2001/XMLSchema#string

P698

19394333

http://www.w3.org/2001/XMLSchema#string

P932

2803092

http://www.w3.org/2001/XMLSchema#string